CollPlant Ltd. (CollPlant) is a biotechnology company. It is engaged in development manufacture and marketing of the collagen biomaterials for the wound care and orthopedic markets. It develops plant-derived collagens, which are used in medical products including bone growth matrices, facial aesthetics, wound dressings, hemostats and sealants. The product portfolio of the company incldue recombinant human type I heterotrimeric atelocollagen, collagen matrix, collagen-based wound dressings, polymer composites and protein-based biomaterials. In addition, CollPlant is developing a pipeline of plant-derived protein polymers and composites used in orthopedics, aesthetic medicine, urinary incontinence and wound healing applications. CollPlant is headquartered in Ness-Ziona, Israel.

Recently, the company signed an agreement with Edwards Lifesciences Corporation, a developer of products and technologies to treat advanced cardiovascular diseases, for the joint development of prototypes of two proprietary collagen-based cardiovascular products.

Street: 
3 Sapir St
City: 
Ness-Ziona
Postcode: 
74140
Federal State : 
Israel
WebSite: 
www.collplant.com
Fax: 
972-73-2325602

Company Index Score

Current Index Score Historical Index Score
  • CollPlant Ltd. currently scores 50 % in the index.
  • CollPlant Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • CollPlant Ltd. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets